MARKET

TOI

TOI

The Oncology Institute Inc
NASDAQ
2.610
+0.160
+6.53%
After Hours: 2.610 0 0.00% 19:55 02/06 EST
OPEN
2.520
PREV CLOSE
2.450
HIGH
2.650
LOW
2.465
VOLUME
1.55M
TURNOVER
--
52 WEEK HIGH
4.880
52 WEEK LOW
0.6015
MARKET CAP
256.78M
P/E (TTM)
-4.0591
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TOI last week (0126-0130)?
Weekly Report · 6d ago
Weekly Report: what happened at TOI last week (0119-0123)?
Weekly Report · 01/26 10:22
Weekly Report: what happened at TOI last week (0112-0116)?
Weekly Report · 01/19 10:28
Buying the Dip on TOI: Strong 2026 Outlook, Underappreciated Profitability, and Valuation Upside
TipRanks · 01/13 12:25
The Oncology Institute Inc. Files Initial Statement of Beneficial Ownership for Director Mark Stolper
Reuters · 01/12 21:57
The Oncology Institute reaffirms 2025 guidance, projects 2026 revenue
Seeking Alpha · 01/12 13:36
Oncology Institute sees FY26 revenue $630M-$650M
TipRanks · 01/12 13:11
Oncology Institute seeks to grow revenue at annual rate of 20% through 2028
TipRanks · 01/12 13:11
More
About TOI
The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Webull offers Oncology Institute Inc stock information, including NASDAQ: TOI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TOI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TOI stock methods without spending real money on the virtual paper trading platform.